Skip to main content
About Medevidex

Built by a clinician,
for healthcare professionals.

01 / The problem

Keeping up with the literature

Medical knowledge grows faster than any clinician can read. Guidelines update yearly, new evidence emerges daily, and the literature that informs clinical decisions sits scattered across PDFs, journals, and institutional repositories.

Existing AI tools either lack access to your specific literature, hallucinate references, or require you to trust answers without citations. None of them treat the source document as the single source of truth.

02 / The solution

Your documents, answered.

Medevidex was built by a clinician who needed a better way to query medical literature. The idea was simple: upload the documents you already have access to, and ask questions that are answered directly from those documents — with every answer citing the exact source, page, and passage.

“Grounded in your literature” is not marketing. Every answer traces back to a document you uploaded. Nothing is fabricated, nothing is anonymous.

The architectural principle
03 / What makes it different

Three architectural commitments

  • Privacy by architecture

    Your documents are tenant-isolated. No cross-user sharing, no staff access, no third-party exposure. This is an architectural guarantee, not a policy promise.

  • Multimodal understanding

    Text, clinical figures, and tables are all indexed. When you ask about a treatment algorithm or a diagnostic image, the system finds and cites the right figure.

  • Citation is the product

    Every answer includes the document name, page number, and relevant passage. An answer without a traceable citation is a failure state in our system.

04 / The team

A clinician-built project

Medevidex is built and operated by Dr Badrulhisham Bahadzor, a consultant urologist based in Malaysia. The project combines clinical experience with a passion for making evidence-based practice more accessible through technology.

05 / Contact

Get in touch

For general enquiries, feature requests, partnership discussions, or rights holder questions:

Email
[email protected]

We aim to respond within 48 hours.